Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Arcadia Biosciences (RKDA) over the last 11 years, with Q3 2025 value amounting to 0.58%.

  • Arcadia Biosciences' Return on Capital Employed fell 3900.0% to 0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year decrease of 3900.0%. This contributed to the annual value of 0.26% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that Arcadia Biosciences reported Return on Capital Employed of 0.58% as of Q3 2025, which was down 3900.0% from 0.47% recorded in Q2 2025.
  • Over the past 5 years, Arcadia Biosciences' Return on Capital Employed peaked at 0.14% during Q1 2025, and registered a low of 0.96% during Q2 2022.
  • In the last 5 years, Arcadia Biosciences' Return on Capital Employed had a median value of 0.47% in 2025 and averaged 0.49%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 11500bps in 2021, then plummeted by -7500bps in 2022.
  • Over the past 5 years, Arcadia Biosciences' Return on Capital Employed (Quarter) stood at 0.76% in 2021, then grew by 19bps to 0.62% in 2022, then rose by 29bps to 0.44% in 2023, then rose by 30bps to 0.31% in 2024, then crashed by -87bps to 0.58% in 2025.
  • Its last three reported values are 0.58% in Q3 2025, 0.47% for Q2 2025, and 0.14% during Q1 2025.